NGM BIOPHARMACEUTICALS INC Quarterly Common Stock, Shares Authorized from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Ngm Biopharmaceuticals Inc quarterly Common Stock, Shares Authorized history and growth rate from Q4 2018 to Q4 2023.
  • Ngm Biopharmaceuticals Inc Common Stock, Shares Authorized for the quarter ending December 31, 2023 was 400M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 400M 0 0% Dec 31, 2023 10-K 2024-03-11
Q3 2023 400M 0 0% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 400M 0 0% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 400M 0 0% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 400M 0 0% Dec 31, 2022 10-K 2024-03-11
Q3 2022 400M 0 0% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 400M 0 0% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 400M 0 0% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 400M 0 0% Dec 31, 2021 10-K 2023-02-28
Q3 2021 400M 0 0% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 400M 0 0% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 400M 0 0% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 400M 0 0% Dec 31, 2020 10-K 2022-03-01
Q3 2020 400M +271M +210% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 400M +271M +210% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 400M +271M +210% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 400M 0 0% Dec 31, 2019 10-K 2021-03-15
Q3 2019 129M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 129M Jun 30, 2019 10-Q 2019-08-12
Q1 2019 129M Mar 31, 2019 10-Q 2019-05-16
Q4 2018 400M Dec 31, 2018 10-K 2020-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.